A scientist prepares a dissolution apparatus for the testing of medicines
May 22, 2024
Q&A with Robert Plenge: What is Bristol Myers Squibb’s research strategy and where are we taking it? >
Science Firsthand: Translating the promise of cell therapy
April 03, 2024
Science Firsthand: Translating the promise of cell therapy >
Science Firsthand: The pathway to drug discovery
August 10, 2023
Science Firsthand: The pathway to drug discovery >
Scientists at BMS dig deep into disease biology to truly understand cancer and battle it from multiple angles.
May 04, 2023
Using a multimodal toolbox to advance the next generation of cancer treatment >
March 14, 2023
From hypothetical possibility to research reality: The innovation behind TYK2 inhibition >
Meet Mary Jean
September 19, 2022
Meet Mary Jean >
Rupert Vessey, Executive Vice President and President of Research and Early Development
September 18, 2022
Faster, higher, stronger >
Estelle Vester-Blokland, MD, Senior Vice President, Medical Affairs, International Markets
September 18, 2022
From patient to physician: Trading places >
Karin Shanahan, Executive Vice President, Global Product Development and Supply
September 18, 2022
Keep the wheels turning >
Greg Meyers, Chief Digital & Technology Officer
September 12, 2022
Using the power of technology to better serve our patients >
Healthcare professionals
March 31, 2022
The quest to stop cancer from coming back  >
Mixed race healthcare professionals
October 28, 2021
Experts weigh in: immunotherapy in earlier stages of cancer >